Pfizer Sees FY24 Adj. EPS, Revenues Below Market; Stock Down In Pre Market
Drug major Pfizer Inc. (PFE) on Wednesday said it expects higher adjusted earnings and revenues for fiscal 2024, but both below market estimates. In pre-market activity on the NYSE, the shares were losing around 7.
Source: rttnews.com